Santhera Pharmaceuticals Holding AG ( SPHDF) - Stock Earnings
SPHDF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -29.5 million USD | 27.6 million USD |
| 2025Q2 | -49.0 million USD | 30.3 million USD |
| 2025Q4 | -13.1 million USD | 67.0 million USD |
| 2026Q2 Est. | — | — |
SPHDF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 65.1 million USD | 123.0 million USD |
| 2024 | -46.4 million USD | 43.3 million USD |
| 2025 | -62.1 million USD | 97.3 million USD |
| 2026 Est. | — | — |
SPHDF
Price: $23.25
52 week price:
Earnings Per Share: -4.79 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 337.7 million